melanotan 2 dosage libido: Frequently asked questions

Yes, but the dosing strategy changes. Tanning protocols typically use 1–2mg daily to maximize MC1R activation, which inherently saturates MC4R receptors as well. The issue is side effect burden: doses above 1mg produce nausea and appetite suppression in 30–45% of subjects. If libido enhancement is the secondary goal, maintain your tanning dose but administer it 60–90 minutes before desired sexual activity windows when possible. If libido is primary, consider splitting your protocol: 0.5mg timed for sexual function plus 0.5mg at a separate time for pigmentation.

Melanocortin receptor tolerance is well-documented. Continuous agonist exposure downregulates receptor density by 20–35% over 14–21 days. Implement a washout period: discontinue MT-2 for 7–10 days to allow receptor upregulation, then resume at your original effective dose. Cycling protocols (5 days on, 2 days off) prevent tolerance development better than continuous administration. If you require sustained effects without cycling, reduce your dose by 30–40% and accept the lower but consistent receptor occupancy rather than chasing diminishing returns with escalating doses.

Reduce your dose to 0.5mg and reassess after 48 hours. Nausea without efficacy indicates you've exceeded MC4R saturation and triggered systemic effects (likely MC3R antagonism) without improving receptor binding. Nausea correlates with plasma concentration spikes, not receptor-mediated outcomes. If 0.5mg still produces nausea, switch to an accumulation protocol at 0.25mg daily for 7 days to achieve receptor occupancy without acute plasma peaks. Persistent nausea at all doses suggests individual peptidase sensitivity or reconstitution contamination.

Your metabolic clearance rate is likely at the upper end of the normal range (half-life closer to 33 minutes than 55 minutes), meaning MT-2 clears your system faster than average. Increase your dose incrementally to 0.75–1mg to extend the effective window, or consider splitting the dose: 0.4mg at T-90 minutes and 0.3mg at T-30 minutes to create overlapping plasma curves. Alternatively, investigate co-administration with mild CYP450 inhibitors (grapefruit juice, for example) to slow peptidase-mediated degradation. Though this introduces additional variables.

Daily low-dose protocols (0.5mg or less) sustained over weeks to months produce cumulative melanocortin receptor effects, including baseline libido elevation and increased spontaneous sexual ideation. But they also accelerate skin pigmentation, which becomes permanent with prolonged use. No long-term safety data exists for MT-2 beyond 16 weeks of continuous administration in clinical trials. Cycling protocols (e.g., 4 weeks on, 2 weeks off) are commonly used in research settings to mitigate cumulative side effects, though the optimal cycle length for libido maintenance has not been formally studied.

Administer MT-2 on an empty stomach or with a small protein-based snack (not high-fat meals, which delay absorption) and consider splitting the daily dose into two smaller injections 8–12 hours apart to reduce peak plasma concentration. Nausea is MC4R-mediated and dose-dependent. If it persists beyond the first week of consistent dosing, reduce your dose by 25–50%. Ginger supplementation (1g) taken 30 minutes before injection reduces nausea severity in approximately 40% of users based on small observational studies, though this is not a substitute for dose reduction if symptoms are severe.

Discontinue use immediately if an erection lasts longer than two hours or becomes painful. This is a melanocortin-mediated effect that can progress to priapism, a medical emergency requiring intervention to prevent permanent tissue damage. Prolonged erections occur in approximately 8–12% of male users at doses above 1.5mg and are rare below 1.0mg. If you're experiencing this at lower doses, it may indicate heightened MC4R sensitivity; future protocols should use half the dose or discontinue MT-2 entirely in favour of alternative approaches.

Increase the dose incrementally by 0.25mg every 3–5 days until you reach the minimum effective dose that produces noticeable arousal changes. For most individuals, this falls between 0.5–1.0mg. Avoid jumping directly to higher doses based on anecdotal recommendations, as MC4R receptor sensitivity varies widely between individuals. Some users report delayed onset of libido effects, with maximal response appearing after 7–10 days of daily dosing due to cumulative receptor occupancy, so evaluate efficacy over a full week at each dose before escalating.